CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval ...Middle East

Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year. Medscape Medical News

Hence then, the article about crispr based gene therapy earns beta thalassemia approval was published today ( Thursday 18/01/2024 - 01:32 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval )

Also on site :

• We Asked 5 Oncology Experts What They Never Eat and They All Said the Same Thing
• Limoncello: Bringing the flavors and spirit of Italy to La Mesa 
• Trinity Rodman, 24, Steals the Spotlight at USA vs. Australia World Cup Match as Fans Call Her a 'Good Luck Charm'